Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Neurotrope, Inc. (NTRP)
|
Add to portfolio |
|
|
|
| Price: |
$1.08
| | Metrics |
| OS: |
23.8
|
M
| |
44
|
% ROE
|
| Market cap: |
$25.7
|
M
| |
3282
|
% ROIC
|
|
Net cash:
|
$27
|
M
| |
$1.13
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$72.2
|
M
| |
0.0
|
x EV/EBITDA
|
|
EBIT
|
$72.2
|
M
| |
0.0
|
x EV/EBIT
|
| EPS |
$0.65
| |
1.7
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Jan-31-13 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | | | | | | | | 1.1% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | -2.1 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | | | | | 0.0% |
| Research and development | 4.5 | 4.6 | 4.5 | 5.6 | 2.2 | 1.2 | | |
| General and administrative | 6.7 | 4.0 | 5.5 | 3.4 | 3.7 | 4.5 | 1.7 | 0.0 |
| EBIT | 14.8 | 10.9 | -12.6 | -12.9 | -9.4 | -9.3 | -7.6 | 0.0 |
| EBIT margin | | | | | | | | -100.0% |
| Pre-tax income | 15.1 | 11.0 | -12.6 | -12.9 | -9.4 | -9.3 | -7.6 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 15.1 | 11.0 | -12.6 | -12.9 | -9.7 | -10.9 | -8.6 | 0.0 |
| Net margin | | | | | | | | -101.0% |
| |
| Diluted EPS | $1.16 | $1.37 | ($1.64) | ($5.69) | ($11.64) | ($0.49) | ($0.40) | $0.00 |
| Shares outstanding (diluted) | 13.0 | 8.1 | 7.7 | 2.3 | 0.8 | 22.1 | 21.7 | 10.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|